Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pseudomonas

ABSTRACT: Whole genome sequencing of carbapenem non-susceptible Pseudomonas in a Singapore hospital

PROVIDER: PRJNA656645 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12669000_1.fastq.gz	Fastqsanger.gz
	SRR12669000_2.fastq.gz	Fastqsanger.gz
	SRR12669001_1.fastq.gz	Fastqsanger.gz
	SRR12669001_2.fastq.gz	Fastqsanger.gz
	SRR12669002_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 734

Similar Datasets

Enterobacteriaceae

Project description:Whole genome sequencing of carbapenem non-susceptible Enterobacterales in a Singapore hospital

| PRJNA577535 | ENA

Acinetobacter

Project description:Whole genome sequencing of carbapenem non-susceptible Acinetobacter in a Singapore hospital

| PRJNA664284 | ENA

Project description:Pseudomonas aeruginosa carbapenem resistant and susceptible isolates, Singapore

| PRJNA1197548 | ENA

Carbapenem-susceptible Gram negative bacteria

Project description:Carbapenem-susceptible Gram negative bacteria sequences from a Singapore Hospital

| PRJNA1281836 | ENA

Project description:Carbapenem non susceptible Pseudomonas aeruginosa from a hospital in southern Lima

| PRJNA1368302 | ENA

Pseudomonas aeruginosa Jakarta

Project description:Clinical samples from a genomic characterization of Carbapenem-non-susceptible Pseudomonas aeruginosa strains from two ICUs from the referral national hospital in Jakarta, Indonesia.

| PRJEB30625 | ENA

Environmental Pseudomonas aeruginosa Jakarta

Project description:Environmental samples from a genomic characterization of Carbapenem-non-susceptible Pseudomonas aeruginosa strains from two ICUs from the referral national hospital in Jakarta, Indonesia.

| PRJEB32907 | ENA

Pseudomonas aeruginosa

Project description:Carbapenem-resistant Pseudomonas aeruginosa strains in a hospital in Japan

| PRJDB20638 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Pseudomonas aeruginosa

Project description:Carbapenem resistant Pseudomonas aeruginosa from two time periods in a Houston Hospital

| PRJNA896240 | ENA